lead plaintiff

248 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Kirby Mcinerney Llp

Upstart Investors Face June 2026 Deadline in Securities Class Action Over Faulty AI Model

Law firm Kirby McInerney LLP reminds Upstart investors of June 8, 2026 deadline to join securities lawsuit alleging the company's Model 22 AI overstated accuracy and loan approvals.
UPSTrevenue guidancesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Kirby Mcinerney Llp

POET Technologies Hit with Securities Fraud Lawsuit Over PFIC Disclosure Failures

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.
POETsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Graphic Packaging Hit With Class Action Over Alleged Misstatements on Inventory, Demand

Graphic Packaging faces class action lawsuit alleging executives misrepresented inventory issues, demand weakness, and cost pressures from Feb 2025-Feb 2026.
GPKsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Law Offices Of Howard G. Smith

Four Public Companies Face Securities Fraud Class Actions; Investor Deadlines Loom

Four public companies face securities fraud class actions with mid-to-late June 2026 lead plaintiff deadlines. Investors alleged false statements about business operations and financial prospects.
STLALKQGLOBsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Gross Law Firm

Lufax Shareholders Face May Deadline in Securities Fraud Class Action

The Gross Law Firm reminds Lufax Holding Ltd investors of May 20, 2026 deadline to join securities class action alleging false statements and control failures.
LUshareholder lawsuitsecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··The Gross Law Firm

Stellantis Faces Securities Lawsuit Over €22B Charge; Investor Deadline Looms

The Gross Law Firm announced securities class action against $STLA for allegedly misleading investors on earnings and EV capabilities, triggering 23.69% stock decline.
STLALUPOETsecurities class actionstock price decline
GlobeNewswire Inc.GlobeNewswire Inc.··The Gross Law Firm

HTGC Faces Securities Class Action Over Alleged Due Diligence Failures

$HTGC securities lawsuit alleges false statements on due diligence, loan origination, and portfolio valuation. Lead plaintiff deadline: May 19, 2026.
HCXYHTGCshareholder lawsuitsecurities class action
BenzingaBenzinga··Law Offices Of Howard G. Smith

Lufax Shareholders Sue Over Fraud Allegations; Class Action Opens for Lead Plaintiffs

Law firm launches securities fraud lawsuit against Lufax Holding Ltd. ($LU), alleging undisclosed control weaknesses and financial misstatements from April 2023 through January 2025.
LUsecurities fraudclass action lawsuit
BenzingaBenzinga··Law Offices Of Howard G. Smith

Globant Faces Securities Fraud Lawsuit Over Undisclosed Latin America Struggles

Globant faces securities fraud lawsuit alleging concealment of Latin American demand declines, wage freezes, and project cancellations from February 2024 through August 2025.
GLOBsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Alight Faces Class Action Over CEO Projections, Investor Window Closes May 15

Class action lawsuit filed against Alight alleging executives misled investors on growth prospects and capital returns. Lead plaintiff deadline set for May 15, 2026.
ALITsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Coty Faces Class Action Lawsuit Over Misleading Growth Statements

Law firm urges $COTY shareholders with losses to join class action suit alleging false statements on beauty market growth and margin compression. Deadline: May 22, 2026.
COTYclass action lawsuitinvestor losses
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Atara Biotherapeutics Faces Class Action Over FDA Approval Claims

Class action lawsuit filed against Atara Biotherapeutics alleges false statements about FDA approval prospects. Investors must seek lead plaintiff status by May 22, 2026.
ATRAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Lufax Faces Class Action Lawsuit Over False Financial Disclosures

Class action lawsuit filed against Lufax Holding Ltd alleging false financial statements and internal control disclosures from April 2023 to January 2025.
LUsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Lufax Faces Securities Fraud Class Action Over False Financial Statements

Class action lawsuit filed against $LU alleging securities fraud and inadequate internal controls. Covers investors from April 2023 to January 2025.
LUsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

ODDITY Tech Faces Securities Fraud Lawsuit Over Misleading Ad Model Claims

$ODD faces securities fraud lawsuit alleging false statements about ad model. Stock fell 49% after disclosing partner algorithm change causing 30% Q1 revenue decline projection.
ODDsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

FS KKR Capital Faces Class Action Over Valuation Claims as NAV Declines Sharply

Class action lawsuit alleges FS KKR Capital made false statements about portfolio valuations, restructuring, and dividend sustainability amid significant NAV declines and rising non-accruals.
FSKsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Nektar Therapeutics Faces Securities Lawsuit Over REZOLVE-AA Trial Disclosures

Nektar Therapeutics faces securities class action lawsuit alleging false statements about REZOLVE-AA trial. Lead plaintiff deadline set for May 5, 2026.
NKTRsecurities class actionlead plaintiff
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Trip.com Hit With Class Action Over Alleged Monopoly Disclosure Failures

Trip.com faces class action alleging inadequate disclosure of monopoly-related regulatory risks. Investors harmed from April 2024 to January 2026 can join the lawsuit by May 11, 2026.
TCOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

POET Technologies Faces Class Action Over PFIC Tax Disclosure Failures

Rosen Law Firm files class action against $POET Technologies for alleged false PFIC tax statements and failure to disclose negative U.S. shareholder implications.
POETsecurities class actionlead plaintiff
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Class Action Lawsuit Filed Against Concorde International Over Alleged Fraud Scheme

Class action lawsuit filed against $CIGL for false statements, social media manipulation, insider share dumping, and undisclosed risks. Lead plaintiff deadline: May 18, 2026.
YOOVsecurities fraudclass action lawsuit